Sven Branner
Impact in
- Toxicology top 1%
- Bioactive Compounds and Antitumor Agents
- Oncology top 5%
- Peptidase Inhibition and Analysis
Papers in
-
- Protein Tyrosine Phosphatases 9
-
- Enzyme Structure and Function 9
- Co-authors
- Hanne B. Rasmussen (4 shared papers)Nicolai Wagtmann (3 shared papers)Finn C. Wiberg (1 shared paper)Niels Peter Hundahl Møller (9 shared papers)Henrik Sune Andersen (7 shared papers)Lars Iversen (7 shared papers)Karin Möller (6 shared papers)Steen B. Mortensen (6 shared papers)
- Journals
- Journal of Biological Chemistry (5 papers)Advances in experimental medicine and biology (3 papers)Journal of Molecular Biology (2 papers)Protein Engineering Design and Selection (2 papers)FEBS Letters (2 papers)
- Partner nations
- DenmarkGermanyUnited States
In The Last Decade
Sven Branner
26 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 88
- Toxicology 127
- Oncology 499
- Immunology 391
- Biotechnology 163
- Cellular and Molecular Neuroscience 278
Countries citing papers authored by Sven Branner
This map shows the geographic impact of Sven Branner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven Branner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven Branner more than expected).
Fields of papers citing papers by Sven Branner
This network shows the impact of papers produced by Sven Branner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven Branner. The network helps show where Sven Branner may publish in the future.
Co-authors
The 25 scholars most cited alongside Sven Branner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 338 | |
| 2 | 2002 | 151 | |
| 3 | 2000 | 149 | |
| 4 | 1992 | 126 | |
| 5 | 2002 | 110 | |
| 6 | 2000 | 105 | |
| 7 | 2006 | 97 | |
| 8 | 2004 | 67 | |
| 9 | 2004 | 64 | |
| 10 | 2001 | 60 | |
| 11 | 2000 | 42 | |
| 12 | 1993 | 34 | |
| 13 | 1993 | 33 | |
| 14 | 1990 | 32 | |
| 15 | 2003 | 22 | |
| 16 | 1994 | 19 | |
| 17 | 1994 | 18 | |
| 18 | 1991 | 16 | |
| 19 | 1996 | 13 | |
| 20 | 1994 | 11 |
About Sven Branner
Sven Branner is a scholar working on Molecular Biology, Materials Chemistry, Immunology, Biotechnology and Cellular and Molecular Neuroscience, having authored 27 papers that have together received 1.5k indexed citations. Recurring topics across this work include Enzyme Structure and Function (9 papers), Protein Tyrosine Phosphatases (9 papers), Galectins and Cancer Biology (8 papers), Enzyme Production and Characterization (7 papers), Bioactive Compounds and Antitumor Agents (3 papers), Peptidase Inhibition and Analysis (3 papers), Neuropeptides and Animal Physiology (3 papers) and Diabetes Treatment and Management (2 papers). The work is most often cited by research in Toxicology (127 citations), Oncology (499 citations), Immunology (391 citations), Biotechnology (163 citations) and Cellular and Molecular Neuroscience (278 citations). Sven Branner has collaborated with scholars based in Denmark, Germany and United States. Frequent co-authors include Hanne B. Rasmussen, Nicolai Wagtmann, Finn C. Wiberg, Niels Peter Hundahl Møller, Henrik Sune Andersen, Lars Iversen, Karin Möller, Steen B. Mortensen, Günther H. Peters and Keith S. Wilson. Their work appears in journals such as Journal of Biological Chemistry, Advances in experimental medicine and biology, Journal of Molecular Biology, Protein Engineering Design and Selection and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.